Vicki L. Sato - 30 Jul 2021 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
30 Jul 2021
Net transactions value
$0
Form type
3
Filing time
03 Aug 2021, 17:28:57 UTC
Previous filing
23 Jul 2021
Next filing
20 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ALLO Stock Option (Right to Buy) 30 Jul 2021 Common Stock 3,000 $36.31 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 50% of the shares subject to the stock option vested on October 31, 2020 and 50% of the shares subject to the stock option vested on February 28, 2021.